Mbx Biosciences Inc (MBX) Annual Income Statement

Annual · GAAP · USD millions
Access MBX quarterly income statements →
From Mbx Biosciences Inc through , changes in Dec 31 2025's revenue and cost structure provide insight into profitability trends.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/MBX/income-statements
https://api.csimarket.com/api/v1/companies/MBX/fundamentals
https://api.csimarket.com/api/v1/companies/MBX/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
2025
(Dec 31 2024)
Revenues
Total Revenue0.00
Costs & Expenses
Gross Profit0.00
Selling, Administration, Marketing18.90
Research & Development79.16
Total operating costs including COS98.06
Operating income / -loss-98.06
Interest Income-11.08
Net Interest (-)Expense / Income11.08
Other loss / -income0.00
Total costs & expenses86.97
Income & Taxes
Income / -loss before income taxes-86.97
Income after income taxes-86.97
Income / -loss from continuing operations-86.97
Net income / -loss-86.97
Income / -loss to shareholder-86.97
EBIT-98.06
EBITD-97.81
EBITDA-97.81
Earnings Per Share
Basic EPS (excl. extra items)-2.38
Basic Net EPS-2.38
Basic shares outstanding (Mill. of Units)36.51
Diluted Net EPS-2.38
Diluted average shares (Mill. of Units)36.51
4 historic quarters locked

Sign in to unlock the full Mbx Biosciences Inc income statement history.

About Mbx Biosciences Inc Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-K filings
  • Filed with the SEC: March 12, 2026
  • Original filing: mbx-20251231.htm

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI